For the vast majority of people with diabetes, their bodies need to be monitored daily,media BGR reported. Their bodies are naturally short of insulin, which means constantmonitoring of blood sugar levels and insulin injections to ensure that their bodies perform important processes and remain alert and healthy. Now, researchers studying the disease have come up with a potential solution that could lead to a cure, even if it appears to be only in laboratory mice. The treatment involves the use of stem cells, which can be naturally converted into other cells in the body to complete insulin secretion and reduce the need for artificial treatment of the disease.
When treated, stem cells are converted into beta cells that secrete insulin. Researchers have been working on the technique for a long time, but in the process they have had to overcome some very serious obstacles, including the transformation of stem cells into other types of cells that do not help treat diseases.
Stem cells, like blank slates, can be turned into many different kinds of cells. This makes them extremely powerful in treating a variety of diseases, but it also means that they may be an uncertain factor that becomes cells that researchers cannot anticipate. This means that more and more stem cells are needed to produce the target number of beta cells.
“The more off-target cells you get, the fewer cells associated with the treatment,” explains lead researcher Jeffrey Millman. “You need about a billion beta cells to cure a diabetic. But if you make a quarter of the cells you make are actually liver cells or other pancreatic cells, rather than needing a billion cells, you’ll need 1.25 billion cells. It makes it 25% more difficult to cure the disease. “
To test their methods, researchers have been working on a new technique that could improve the efficiency of converting to beta cells. The team says they now know enough information to better predict how many cells will work as expected, making treatment more effective.
In laboratory mice, rodent diseases have been “functionally cured”, which in itself is a remarkable achievement. However, it remains to be seen whether the same results can be replicated in humans. Still, this is an exciting development and could be good news for people with diabetes.